Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Gastroenterology
•
Advanced Endoscopy
What factors influence your choice of EMR vs ESD vs FTR for gastric neoplastic lesions?
Related Questions
What do you consider an optimal interval of time to repeat necrosectomies for treatment of WON?
Do you routinely use single-use duodenoscopes for ERCPs in patients with a history of infections secondary to MDR organisms?
Which patients would benefit from pancreatic duct stents in combination with rectal indomethacin for prophylaxis against post-ERCP pancreatitis?
In which patients do you recommend endoscopic bariatric procedures (such as endoscopic sleeve gastroplasty) instead of laparoscopic bariatric surgery?
Do you feel there is any difference between performing an ERCP with an EDGE together in a single session or separately in two sessions in a patient with Roux-en-Y anatomy?
Under what circumstances would you recommend early fecal microbiota transplantation over antibiotic treatment or bezlotoxumab in a patient with recurrent C. difficile infection?
Which colonic polyp or mass-like lesions do you refer to an advanced endoscopist?
How do you approach managing depression symptoms in patients who have had repeated high risk of bleeding?
How do you approach the treatment of Crohn's colitis in the setting of immunosuppression for liver transplant?
When do you send for genetic testing (e.g., SPINK1, PRSS1, CFTR) in a patient with recurrent or chronic pancreatitis without an obvious etiology and how does it impact your management?
